New malaria breakthrough drug uses human blood as weapon
Medication used to treat river blindness shown to also reduce transmission of the mosquito-spread disease

A breakthrough new drug that could save countless lives is in the pipeline following the discovery that a medication commonly used to combat river blindness can also kill the parasite that spreads malaria.
Ivermectin, a drug discovered in the Streptomyces avermitilis bacteria in 1975, has for more than 25 years been used to kill parasites including lice, mites, worms and nematodes by disrupting the fluid exchange through the insect’s cell membrane.
In March, scientists reported that recent vaccine trials in Burkina Faso using Ivermectin for conditions unrelated to malaria had also seen malarial transmission rates drop significantly.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
According to The Guardian, vaccination with the drug made “the blood of people who were repeatedly vaccinated lethal to mosquitoes”. Further research revealed that Ivermectin “can kill plasmodium falciparum, the malaria parasite carried by female mosquitoes”, the newspaper reports.
Experts now say that a new Ivermectin-based antimalarial drug could be released within two years.
Dr Simon Kariuki, head of the malaria branch at the Kenya Medical Research Institute (Kemri), said that human trials are being planned, adding: “We need more answers on Ivermectin. We need new malaria drugs as soon as possible as drug resistance is not something to ignore and we have to treat the situation as urgent.”
Although deaths from malaria have dropped by roughly 48% since 2000, recent figures show that malaria still killed 435,000 people in 2017, says The Telegraph.
And a study in August this year revealed that resistance to existing antimalarial drugs is increasing worldwide.
However, a paper published by the Yale School of Public Health earlier this year claimed that child malaria episodes could be reduced by up to 20% if populations living in high-risk areas were given Ivermectin.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Canadian man dies in ICE custody
Speed Read A Canadian citizen with permanent US residency died at a federal detention center in Miami
-
GOP races to revise megabill after Senate rulings
Speed Read A Senate parliamentarian ruled that several changes to Medicaid included in Trump's "One Big Beautiful Bill" were not permissible
-
Supreme Court lets states ax Planned Parenthood funds
Speed Read The court ruled that Planned Parenthood cannot sue South Carolina over the state's effort to deny it funding
-
Deadly fungus tied to a pharaoh's tomb may help fight cancer
Under the radar A once fearsome curse could be a blessing
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
'Poo pills' and the war on superbugs
The Explainer Antimicrobial resistance is causing millions of deaths. Could a faeces-filled pill change all that?
-
The marvelous powers of mucus
The Explainer It's snot just a pesky cold symptom
-
The New World screwworm is making a deadly comeback
The explainer The parasite is spreading quickly
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
A tick-borne illness is making its rounds in new parts of America
Under the radar Babesiosis, spread through blacklegged or deer tick bites, is a growing risk